Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets

March 5, 2020, Boston (MA, US), Ghent (Belgium) – Orionis Biosciences is today debuting with the announcement of a major drug discovery collaboration with Novartis. Orionis has developed innovative technologies in genome-scale drug discovery and tunable molecular design of novel therapeutic drug modalities to tackle the industry’s most intractable disease targets. The goal of the…

Learn more